Parkinson's Disease: Genetics

Parkinson’s disease is a progressive neurodegenerative disorder that affects movement. This feed focuses on genetic screening approaches and genetic predispositions in Parkinson’s disease.

April 17, 2021

An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3.

The Journal of Biological Chemistry
Naoya FukuiYasushi Kawata
April 16, 2021
Open Access

Evolutionary Changes in the Interaction of miRNA With mRNA of Candidate Genes for Parkinson's Disease.

Frontiers in Genetics
Saltanat KamenovaAnatoliy Ivashchenko
April 16, 2021
Review
Open Access

Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease.

Molecular Medicine
Shigeki Hirano
April 16, 2021
Open Access

A stress-free strategy to correct point mutations in patient iPS cells.

Stem Cell Research
Jingli CaiLorraine Iacovitti
April 16, 2021

Gene expression profiling of early Parkinson's disease patient reveals redox homeostasis.

Neuroscience Letters
Liwen ZhangLingjing Jin
April 16, 2021

Enhancing Top-Down Proteomics of Brain Tissue with FAIMS.

Journal of Proteome Research
James M FulcherVladislav A Petyuk
April 16, 2021
Open Access

Optogenetic delivery of trophic signals in a genetic model of Parkinson's disease.

PLoS Genetics
Alvaro Ingles-PrietoHarald Janovjak
April 15, 2021
Preprint
Open Access

α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response

BioRxiv : the Preprint Server for Biology
A. DelaidelliAsad Jan
April 16, 2021
Open Access

Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models.

Journal of Tissue Engineering
Ha Na KimPhil Hyu Lee
April 16, 2021
Review
Open Access

Molecular Factors Mediating Neural Cell Plasticity Changes in Dementia Brain Diseases.

Neural Plasticity
Wojciech KozubskiJolanta Dorszewska
April 16, 2021
Review
Open Access

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders.

Frontiers in Neuroscience
Yoo Jin JungNigel H Greig
April 16, 2021
Review
Open Access

Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases.

Genome Medicine
Federica PerroneChristine Van Broeckhoven
April 14, 2021

Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1-dependent TFEB/TFE3 regulation.

EMBO Molecular Medicine
Reini E N van der WelleJudith Klumperman
April 14, 2021
Case Report

Coexistence of dentatorubral-pallidoluysian atrophy and Parkinson's disease: An autopsy case report.

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Seong-Ik KimSung-Hye Park
April 14, 2021
Open Access

DJ-1 affects oxidative stress and pyroptosis in hippocampal neurons of Alzheimer's disease mouse model by regulating the Nrf2 pathway.

Experimental and Therapeutic Medicine
Lin Cheng, Wei Zhang
April 14, 2021
Open Access

Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease.

NPJ Parkinson's Disease
Samantha M CarlisleDavid G Standaert
April 14, 2021
Open Access

Bullous Pemphigoid Mimicking Cellulitis.

Journal of Investigative Medicine High Impact Case Reports
Ilya IvyanskiyTarek M Naguib
April 14, 2021
Review

Parkinson's disease.

Lancet
Bastiaan R BloemChristine Klein

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

© 2021 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-genetics/aafce3ab-6d9e-42a4-9fdd-01b8c3f82139